Walleye Trading Advisors »

Aerovate Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 55k 29.57

More positions owned by Walleye Trading Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Tesla Motors Call Option (TSLA)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Select Sector Spdr Tr Financial Call Option (XLF)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)

View all positions for Walleye Trading Advisors

Top funds holding Aerovate Therapeutics

RA Capital Management
Sofinnova Ventures
TCG Crossover Management
Atlas Venture Life Science Advisors
Baker Bros. Advisors
Frazier Life Sciences Management
Cormorant Asset Management
Dr. Jeffrey R. Jay, M.D.
Driehaus Capital Management
BlackRock
Vanguard Group
OrbiMed Advisors
FMR
Eventide Asset Management
Octagon Capital Advisors

View all funds holding Aerovate Therapeutics